The STEP UP Trial: Semaglutide Treatment Effect in People with Obesity The trial was a randomized, double-blind phase 3b study of 1,400 adults without type 2 diabetes that investigated a higher dose of Semaglutide (7.2 mg weekly) for weight management in adults with obesity
When GH is released, it stimulates the liver to produce IGF-1, which then travels to various tissues to promote growth and repair
Increased Energy Expenditure: Activation of the glucagon receptor encourages the body to break down stored fat and increases the metabolic rate, further supporting weight loss
Nutrients 14 , 631 (2022)
Current Research in Food Science [Internet]
If any of this sounds familiar, start with a mens health physician who will actually dig into your history and provide personalized medical advice for your overall wellness